Picture EBD Group BIO-Europe Spring 2020 Paris BEU2020 650x75
Document › Details

Medicyte GmbH. (6/25/13). "Press Release: Medicyte GmbH and WBM Health Science Pvt Ltd Join Hands for the Promotion of Medicyte’s Products and Services in India". Heidelberg & New Delhi.

Region Region India
Organisations Organisation Medicyte GmbH
  Organisation 2 WBM Health Science Pvt. Ltd.
Products Product upcyte® technology
  Product 2 vericyte® technology
Index term Index term WBM Health Science–Medicyte: cell technology, 201306– collab promotion of Medicyte products + services in India by WBM

Medicyte GmbH, Germany and WBM Health Science Pvt Ltd, India (WBM), today announced that they will join forces for the promotion of Medicyte's cutting edge products and services in India.

WBM is a company comprised of experts with proven expertise in the field of sales and services of Life Sciences, Diagnostics & Specialty Healthcare instrumentation and consumables. Medicyte is known as provider of human primary cells and upcyte® cell strains as well as inventors of the upcyte® and vericyte® technology. By using its unique technologies, Medicyte is capable to offer more predictive, reliable and standardized cell strains and primary cells in sufficient quantities. upcyte® and vericyte® cells strains can easily be applied to cell-based assays for use in research, screening and drug development. The companies will pool their expertise to ensure maximum availability for the innovative products & services in Indian pharma space especially for ADMET application.

"We believe Medicyte has exciting solution which adds value to pharmaceutical research / drug discovery segment," said T. Sinha, Chief Scientific Officer of WBM. "By offering Medicyte's unique value preposition to the Indian Pharmaceutical Research market, the customer will benefit a great deal with these game changing tools which eventually will assist them in their pursuit of tomorrow's most important scientific discoveries."

About WBM Health Science Pvt Ltd

WBM Health Sciences Pvt Ltd (formerly known as Helix Bioservice & Consultants Pvt Ltd) was incorporated in May 2010. WBM aims to deliver technology solutions that will provide our customers with revolutionary and ingenious ways of solving their most pressing business problems. It desires to become a long-term innovation partner of choice across the human care value chain that will deliver proprietary products, frameworks, and solutions with the clear objective of becoming a trusted partner to our customers. It works with global companies across the life science research, drug discovery, pharma research, molecular diagnostics & specialty healthcare space to maintain their competitive edge in India through its unique technology preposition and services targeting:

> For accelerating basic & applied life science research in research labs / academia space, new drug discovery & pharmaceutical research.
> To achieve reduction in cost of ownership to its valued customer on a long-term basis.
> Eventually to be an integral part to our customer's success.

To know more about WBM Health Science Pvt. Ltd, please visit

About Medicyte GmbH

Medicyte is specialized in the controlled generation and standardization of human primary cell products in virtually unlimited quantities and of highest quality for cell therapy and cellbased R&D. Medicyte's proprietary technologies "upcyte®" and "vericyte®" enable the expansion of human primary cells like hepatocytes from different human donors in a standardized manner, thereby, for the first time, making these cells commercially available in high quantities and consistent quality. Increasingly pharmaceutical companies consider using upcyte® Hepatocytes for in vitro ADMET testing as alternatives to primary human cells. In addition Medicyte offers cell culture materials like medium and plates.

Further information can be found at

Record changed: 2019-06-09


Picture Fairtec GmbH Worldwide Event Solutions 650x65px

More documents for Medicyte GmbH

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]


Picture EBD Group BIO-Europe Spring 2020 Paris BEU2020 650x75

» top